News
Novo Nordisk is looking to partner with digital companies at every stage of the weight loss journey to help patients lose ...
Orion Corporation has broadened its partnership with Glykos, focusing on the development of antibody-drug conjugates (ADCs).
The FDA launched a new Priority Review program, as uncertainty persists for the existing programme for paediatric disorders.
The test is currently available in private healthcare facilities but there are hopes it may be adopted by the NHS.
Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...
Lisata Therapeutics has formed a strategic partnership with GATC Health for advancing AI-driven drug discovery and ...
The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...
Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...
European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...
Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...
Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.
Shares in both companies were down following news of the second death, casting fresh safety concerns over Elevidys.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results